Migrating point-to-point lab interfaces to middleware
A phased approach for lab supervisors and IT: pilot analyzer, parallel path, cutover slices, rollback criteria — without a big-bang weekend.
- lab middleware
- interface migration
- LIS
- laboratory informatics
- change management
What “interface migration” means here
Many labs still run point-to-point links: each analyzer talks directly to the LIS (or through a one-off box). Laboratory middleware inserts a managed layer: analyzers speak to middleware; middleware speaks to the LIS on one (or few) uplink(s).
Migration is not a single weekend cutover. It is a sequence of evidence-backed slices so clinical release and IT operations stay controllable.
Audience: lab supervisors / QA (clinical safety) and lab IT (connectivity and rollback).
Why big-bang weekends fail
| Pattern | Risk |
|---|---|
| All analyzers flipped Saturday night | One unknown mapping blocks the whole lab |
| No parallel comparison | Escapes discovered by clinicians, not QA |
| Rollback undefined | “Forward only” under pressure |
| Training after go-live | Exception queue becomes a parking lot |
Phased method
Phase 1 — Inventory and scope
For each in-scope analyzer record:
- Model, firmware, host protocol (ASTM/HL7 variant)
- Current path to LIS (direct / box / other)
- Orders down / results up / both
- Known quirks from the Host Interface Manual
Freeze scope: what is in this migration wave vs later.
Phase 2 — Pilot instrument
Choose one representative analyzer (not the most exotic first).
Success criteria before expanding:
- Bidirectional proof (orders down and results up)
- Visible stuck-message location
- Mapping owners named
- Rollback path documented (restore prior path or disable channel)
Phase 3 — Parallel path
Run middleware alongside the legacy path long enough to compare:
- Result identity (specimen, test, value, flags)
- Correction behaviour
- Hold / release decisions if autoverification is in scope
Define escape criteria (what counts as a mismatch). Prefer narrow assay families before whole menus.
Phase 4 — Cutover slices
Cut over by instrument or assay family, not by “the whole lab.”
For each slice:
- Pre-change checklist (firmware pin, mapping export, uplink health)
- Cutover window with named owners on call
- Immediate smoke tests (order + result + one reject path)
- Hypercare period with exit criteria
Phase 5 — Decommission legacy path
Only after smoke tests and a quiet period:
- Disable or remove the old point-to-point channel
- Update network diagrams and SOPs
- Archive golden messages from the parallel phase
Rollback criteria (write them down)
Examples of automatic rollback triggers:
- Unable to send results to LIS within agreed SLA
- Specimen ID mismatches above threshold
- Critical assay family blocked without a staffed manual path
Rollback is a controlled change, not an admission of failure.
Checklist
- Signed inventory for the migration wave
- Pilot success criteria met
- Parallel comparison plan and escape definition
- Slice order agreed with lab leadership
- Rollback procedure rehearsed once
- SOPs and training updated before each slice
FAQ
Should autoverification go live on day one of migration?
Usually no. Prove connectivity and mapping first; encode and validate AV afterward on a stable pipe.
How long should parallel run?
Long enough to cover representative volume and at least one correction path — measured in evidence, not calendar dogma.
What if the LIS vendor wants a big-bang?
Keep clinical and IT risk acceptance with the laboratory. Slice plans can still align with LIS vendor windows without flipping every analyzer at once.
Related reading
- Interface debt is killing your turnaround
- Middleware implementation without the project spiral
- LIS interface requirements
- Supported interfaces
About TransLABtor
TransLABtor supports phased instrument onboarding behind a standard LIS uplink. Site validation and cutover authority remain with the laboratory. Contact for scoping a migration wave.